Chronic pancreatitis: what should be considered in diagnosis, treatment, and prognosis

Author: T. N. Khristich Yuriy Fedkovych Chernivtsi National University, Ukraine Summary The aim of the

Prognosismodifying therapy in patients with CAD: how to optimize treatment?

Authors: Khanyukov A.A., Professor, Doctor of Medical Sciences, Head of the Department of Internal Medicine,

Clinical case of acute pancreatitis associated with COVID-19 vaccination

Authors: N. B. Gubergrits1, Yu. M. Alkhazov2, N. A. Abdullaeva3 1 Into Sana” Multifield Clinic,

Diaphragmatic hernia: mechanisms of formation, clinic, treatment tactics

Authors: N. B. Gubergrits, N. V. Byelyayeva, A. Ye. Klochkov, G. M. Lukashevich, P.G. Fomenko,

Experience of using pantoprazole in the complex therapy of diseases of the digestive tract of different age groups

Authors: Iu.V. Marushko, A.O. Asonov, O.O. Bogomolets National Medical University, Kyiv Summary Gastroesophageal reflux disease

Experience of using pantoprazole (Ulsepan) and a combined synbiotic (Opefera) in the complex therapy of children with gastroesophageal reflux disease and gastroduodenitis

Authors: Yu.V. Marushko, A.O. Asonov, Bogomolets National Medical University, Kyiv Summary One of the relevant

Modern approaches to the treatment and prevention of gastrointestinal bleeding associated with NSAID gastropathy and stress ulcers

Author: S. M. Tkach, Doctor of Medical Sciences, Chief Researcher of the Ukrainian Scientific and

Ulsepan (pantoprazole) as an effective means of preventing erosive and ulcerative lesions of the gastroduodenal zone in patients during surgical interventions on the organs of the gastrointestinal tract

Authors: O.Yu. Usenko, M.V. Manoilo, I.V. Babii, State Institution «O.O. Shalimov National Institute of Surgery

Drug prevention and treatment of gastropathies associated with the use of non-steroidal anti-inflammatory drugs

Authors: E. V. Kolesnikova, T. A. Solomentseva, National Institute of Therapy named after L. T.

Selecting the Optimal Proton Pump Inhibitor for Patients with Coronary Artery Disease Who Require Dual Antiplatelet Therapy

Authors: O.O. Khaniukov, O.V. Pysarevska, M.G. Getman, T.A. Simonova, T.V. Lakiza, State Institution «Dnipropetrovsk Medical

Results of a multicenter study of the effectiveness of Helicobacter pylori eradication, carried out in accordance with the recommendations of the Maastricht Consensus V

Аuthors: O. V. Shvets 1, О. O. Bondarenko 2, O. M. Аgibalov 3, N. I.

The use of pantoprazole in the prevention of NSAID gastropathy

On the Ukrainian market, World Medicine presents the drug pantoprazole Ulsepan, which has proven its

ULSEPAN: pantoprazol 40 mg

The high efficacy of proton pump inhibitors (PPIs) makes this class of drugs one of